Lupus anticoagulant detection: Out of control?

International Journal of Laboratory Hematology

Volumn 35, Issue 2, 2013, Pages 128-136

  Moore, G W ^a   Brown, K L ^a   Bromidge, E S ^a   Drew, A J ^a   Ledford Kraemer, M R ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b CLOT ED Inc   (United States)

Author keywords

Lupus anticoagulant; Normal pooled plasma; Normalised ratios; Reference interval

Indexed keywords

LUPUS ANTICOAGULANT; PROTHROMBIN;

ARTICLE; INTERNATIONAL NORMALIZED RATIO; PERCENTAGE CORRECTION INDEX; PRIORITY JOURNAL; PROTHROMBIN TIME; REFERENCE VALUE;

ANTIPHOSPHOLIPID SYNDROME; BLOOD COAGULATION TESTS; DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC ERRORS; HUMANS; LUPUS COAGULATION INHIBITOR;

EID: 84875052222     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/ijlh.12006     Document Type: Article

References (27)

1. Miyakis S, Lockshin MD, Atsumi D, Branch DW, Brey RL, Cervera R, Derksen RHWM, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
2. Galli M, Barbui T. Antiphospholipid antibodies and pregnancy. Best Pract Res Clin Haematol 2003;16:211-25.
3. Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003;101:1827-32.
4. Greaves M, Cohen H, Machin SJ, Mackie I. Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol 2000;109:704-15.
5. Jennings I, Kitchen S, Kitchen DP, Woods TAL, Walker ID. ISTH/SSC lupus anticoagulant testing guidelines: how far have these been adopted by laboratories? J Thromb Haemost 2011;9:2117-9.
6. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, de Groot PG. Official communication of the scientific and standardization committee on lupus anticoagulant/phospholipid-dependent antibodies: update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009;7:1737-40.
7. Tripodi A. Testing for lupus anticoagulants: all that a clinician should know. Lupus 2009;18:291-8.
8. Keeling D, Mackie I, Moore GW, Greer IA, Greaves M, and British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol 2012;157:47-58.
9. Devreese K, Hoylaerts MF. Challenges in the diagnosis of antiphospholipid syndrome. Clin Chem 2010;56:930-40.
10. Arnout J, Vanrusselt M, Huybrechts E, Vermylen J. Optimisation of the dilute prothrombin time for the detection of lupus anticoagulant by use of a recombinant tissue thromboplastin. Br J Haematol 1994;87:94-9.
11. Lawrie AS, Mackie IJ, Purdy G, Machin SJ. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers. Thromb Haemost 1999;81:758-62.
12. Zhang L, Whitis JG, Embry MB, Hollensead SC. A simplified algorithm for the laboratory detection of lupus anticoagulants; utilization of two automated integrated tests. Am J Clin Pathol 2005;124:894-901.
13. Gardiner C, Mackie IJ, Malia RG, Jones DW, Winter M, Leeming D, Taberner DA, Machin SJ, Greaves M. The importance of locally derived reference ranges and standardised calculation of dilute Russell's Viper venom time results in screening for lupus anticoagulant. Br J Haematol 2000;111:1230-5.
14. Jennings I, Greaves M, Mackie IJ, Kitchen S, Woods TA, Preston FE; UK National External Quality Assessment Scheme for Blood Coagulation. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol 2002;119:364-9.
15. De Laat B, Derksen RH, Reber G, Musial J, Swadzba J, Bozic B, Cucnik S, Regnault V, Forastiero R, Woodhams BJ, De Groot PG. An international multicentre-laboratory evaluation of a new assay to detect specifically lupus anticoagulants dependent on the presence of anti-beta2-glycoprotein autoantibodies. Thromb Haemost 2011;9:149-53.
16. Hirst CF, Poller L. The cause of turbidity in lyophilised plasmas and its effects on coagulation tests. J Clin Pathol 1992;45:701-3.
17. Moore GW, Tugnait S, Savidge GF. Evaluation of a new generation dilute Russell's viper venom time assay system for lupus anticoagulant detection utilising frozen reagents and controls. Br J Biomed Sci 2005;62:127-31.
18. Horowitz GL, Altaie S, Boyd JC, Ceriotti F, Garg U, Horn P, Pesce A, Sine HE, Zakowski J Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline - Third Edition. CLSI document C28-A3c. Wayne, PA, USA: Clinical and Laboratory Standards Institute; 2008.
19. Exner T. Diagnostic methodologies for circulating anticoagulants. Thromb Haemost 1995;74:338-44.
20. Moore GW, Savidge GF. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied. Thromb Res 2006;118:523-8.
21. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisløff F. The lupus ratio test - an interlaboratory study on the detection of lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Thromb Haemost 2000;83:704-8.
22. Tripodi A. Laboratory testing for lupus anticoagulants; a review of issues affecting results. Clin Chem 2007;53:1629-35.
23. Jacobsen EM, Wisløff F. False negative screening tests for lupus anticoagulants - an unrecognised problem? Thromb Res 1996;82:445-51.
24. Moore GW, Henley A, Greenwood CK, Rangarajan S. Further evidence of false negative screening for lupus anticoagulants. Thromb Res 2008;121:477-84.
25. Brandt JT, Barna LK, Triplett DA. Laboratory identification of lupus anticoagulants: results of the second international workshop for identification of lupus anticoagulants. Thromb Haemost 1995;74:1597-603.
26. D'Angelo A, Galli L, Lang H. Comparison of mean normal prothrombin time (PT) with PT of fresh normal pooled plasma or of a lyophilized control plasma (R82A) as denominator to express PT results: collaborative study of the International Federation of Clinical Chemistry. Clin Chem 1997;43:2169-74.
27. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisløff F. The evaluation of clotting times in the laboratory detection of lupus anticoagulants. Thromb Res 2001;104:275-82.